Monday broker round-up

10th Nov 2014 15:34

RBS: Nomura reiterates reduce but lifts target price to 370p from 360p. IAG: Liberum reiterates buy, maintaining 550p target. Royal Dutch Shell: JP Morgan reiterates overweight stance but cuts target to 2,500p from 2,700p. Aveva: Westhouse Securities reiterates add and its target price of 1,780p.

Read more

Broker tips: Serco, Asos, Genel Energy, Aveva

10th Nov 2014 12:45

Analysts showed their disappointment with a poorly-received statement from Serco on Monday, as the outsourcing company announced a profit warning, £1.5bn of write-downs, and a proposed a rights issue. Oriel Securities analysts said the update "provides some colour on the future shape of the group".

Read more

Aveva facing end-market challenges, but Numis stays upbeat

10th Nov 2014 10:24

Plant and marine engineering firm Aveva beat Numis Securities' forecasts with its interim results, though the broker has scaled back its forecasts for the full year. Nevertheless, Numis kept a 'buy' rating and 1,810p target price for the stock. Results for the six months to 30 September were in lin

Read more

London pre-open: FTSE to glide higher after Chinese data, CBI report

10th Nov 2014 07:43

UK stocks are expected to kick off the week with modest gains as investors digest the latest data out from China over the weekend alongside an upbeat forecast for the British economy from CBI. City sources predict the FTSE 100 will open around 15 points higher than Friday's close of 6,567.24. Data

Read more

Aveva announces further cost cuts, expects to meet full-year guidance

10th Nov 2014 07:07

Engineering data and design IT systems provider Aveva saw revenues decline 21% over the six months ended 30 September to reach £85.9m. That was in line with the revised guidance provided by the company in its mid-September trading update. The company attributed the decline to the "material streng

Read more

Friday broker round-up UPDATE

7th Nov 2014 09:44

AstraZeneca: Deutsche Bank increases target price from 4100p to 4350p and reiterates its hold recommendation. AVEVA: Societe Generale reduces target price from 2250p to 2000p, while keeping its buy recommendation. Big Yellow Group: Citi raises target price from 470p to 540p and maintains its neutra

Read more

Wednesday broker round-up UPDATE

5th Nov 2014 10:02

Associated British Foods: Exane raises target price from 3600p to 3700p, keeping its outperform rating. Citi reduces target price from 3200p to 3100p, while upgrading to buy. AVEVA: Liberum Capital reduces target price from 1500p to 1400p and keeps a hold recommendation. Investec reduces target pric

Read more

Thursday broker round-up UPDATE

16th Oct 2014 08:57

Afren: Investec cuts target price from 195p to 120p and reiterates its hold recommendation. Amerisur Resources: Investec lowers target price from 75p to 65p and maintains a buy recommendation. Antofagasta: UBS upgrades from sell to neutral with a target price of 710p. ARM Holdings: Credit Suisse r

Read more

FTSE 250 movers: CSR leads on buy-out deal

15th Oct 2014 15:53

CSR shares leapt after fellow chip designer Qualcomm announced it was buying out the company for 900p a share or £1.56bn - a 36% premium to Tuesday's closing price. Infrastructure group Balfour Beatty saw its share price jump after appointing Qinetiq's chief executive officer Leo Quinn to take up th

Read more

Tuesday broker round-up UPDATE

23rd Sep 2014 09:36

AVEVA: JP Morgan reduces target price from 2450p to 1825p, while leaving its overweight rating unchanged. African Minerals: Credit Suisse reduces target price from 120p to 25p, while leaving its neutral rating unchanged. Aviva: Goldman Sachs ups target price from 490p to 515p and reiterates a neutr

Read more

Broker tips: Aveva, Chemring, Domino Printing

19th Sep 2014 11:16

UBS has substantially reduced its target price for Aveva after the engineering software group's recent profit warning, but has kept a positive stance on the stock, saying "it would be wrong to sell now". The bank slashed its target for the shares from 2,500p to 1,950p though maintained its 'buy' rat

Read more

UBS keeps the faith in Aveva despite recent profit warning

19th Sep 2014 10:25

UBS has substantially reduced its target price for Aveva after the engineering software group's recent profit warning, but has kept a positive stance on the stock, saying "it would be wrong to sell now". The bank slashed its target for the shares from 2,500p to 1,950p though it maintained its 'buy'

Read more

Petrofac chief financial officer acquires 20,000 shares

16th Sep 2014 16:17

Tim Weller, the chief financial officer of Petrofac, has acquired 20,000 shares in the oil and gas group. The director spent 510.50p on each of shares, giving the deal a total trade value of £206,606. The transaction takes Weller's stake in the company to 77,068. It comes just a few weeks after th

Read more

FTSE 250 movers: Micro Focus jumps on M&A news

15th Sep 2014 15:46

UK software group Micro Focus International is to merge with The Attachmate Group in a $2.4bn deal which "presents a rare opportunity to achieve a significant increase in the scale and breadth" of the business. The company also assured investors that its previously announced 60p-a-share (£84m) cash

Read more

Credit Suisse slashes Aveva target by 19% after profit warning

15th Sep 2014 09:22

Credit Suisse has slashed its target price for Aveva by nearly a fifth after a profit warning from the engineering software firm last week. The bank has cut its target for the shares by 19% from 2,100p to 1,700p and kept a 'neutral' stance. Aveva announced on Friday that first-half revenues would b

Read more